Cargando…

Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer

The focus of this research is to design a bioengineered drug delivery vehicle that is efficient in anti-cancer drug delivery in a controlled manner. The experimental work focuses on constructing a methotrexate-loaded nano lipid polymer system (MTX-NLPHS) that can transport methotrexate (MTX) in MCF-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Rahul, Srivastava, Vinish Ranjan, Mahapatra, Supratim, Dkhar, Daphika S, Kumari, Rohini, Prerna, Kumari, Dubey, Vikash Kumar, Chandra, Pranjal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925353/
https://www.ncbi.nlm.nih.gov/pubmed/36793351
http://dx.doi.org/10.7150/ntno.81173
_version_ 1784888049442750464
author Kumar, Rahul
Srivastava, Vinish Ranjan
Mahapatra, Supratim
Dkhar, Daphika S
Kumari, Rohini
Prerna, Kumari
Dubey, Vikash Kumar
Chandra, Pranjal
author_facet Kumar, Rahul
Srivastava, Vinish Ranjan
Mahapatra, Supratim
Dkhar, Daphika S
Kumari, Rohini
Prerna, Kumari
Dubey, Vikash Kumar
Chandra, Pranjal
author_sort Kumar, Rahul
collection PubMed
description The focus of this research is to design a bioengineered drug delivery vehicle that is efficient in anti-cancer drug delivery in a controlled manner. The experimental work focuses on constructing a methotrexate-loaded nano lipid polymer system (MTX-NLPHS) that can transport methotrexate (MTX) in MCF-7 cell lines in a controlled manner through endocytosis via phosphatidylcholine. In this experiment, MTX is embedded with polylactic-co-glycolic acid (PLGA) in phosphatidylcholine, which acts as a liposomal framework for regulated drug delivery. Scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and dynamic light scattering (DLS) were utilized to characterize the developed nanohybrid system. The particle size and encapsulation efficiency of the MTX-NLPHS were found to be 198 ± 8.44 nm and 86.48 ± 0.31 %, respectively, which is suitable for biological applications. The polydispersity index (PDI) and zeta potential of the final system were found to be 0.134 ± 0.048 and -28 ± 3.50 mV, respectively. The lower value of PDI showed the homogenous nature of the particle size, whereas higher negative zeta potential prevented the system from agglomeration. An in vitro release kinetics was conducted to see the release pattern of the system, which took 250 h for 100% drug release This kind of system may carry the drug for a long time in the circulatory system and prevent the drug discharge. Other cell culture assays such as 3-(4, 5-dimethyl thiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) and reactive oxygen species (ROS) monitoring were used to see the effect of inducers on the cellular system. MTT assay showed cell toxicity of MTX-NLPHS reduced at the lower concentration of the MTX, however, toxicity increased at the higher concentration of the MTX as compared to free MTX. ROS monitoring c revealed more scavenging of ROS using MTX-NLPHS as compared to free MTX. Confocal microscopy suggested the MTX-NLPHS induced more nuclear elongation with cell shrinkage comparatively.
format Online
Article
Text
id pubmed-9925353
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-99253532023-02-14 Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer Kumar, Rahul Srivastava, Vinish Ranjan Mahapatra, Supratim Dkhar, Daphika S Kumari, Rohini Prerna, Kumari Dubey, Vikash Kumar Chandra, Pranjal Nanotheranostics Research Paper The focus of this research is to design a bioengineered drug delivery vehicle that is efficient in anti-cancer drug delivery in a controlled manner. The experimental work focuses on constructing a methotrexate-loaded nano lipid polymer system (MTX-NLPHS) that can transport methotrexate (MTX) in MCF-7 cell lines in a controlled manner through endocytosis via phosphatidylcholine. In this experiment, MTX is embedded with polylactic-co-glycolic acid (PLGA) in phosphatidylcholine, which acts as a liposomal framework for regulated drug delivery. Scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and dynamic light scattering (DLS) were utilized to characterize the developed nanohybrid system. The particle size and encapsulation efficiency of the MTX-NLPHS were found to be 198 ± 8.44 nm and 86.48 ± 0.31 %, respectively, which is suitable for biological applications. The polydispersity index (PDI) and zeta potential of the final system were found to be 0.134 ± 0.048 and -28 ± 3.50 mV, respectively. The lower value of PDI showed the homogenous nature of the particle size, whereas higher negative zeta potential prevented the system from agglomeration. An in vitro release kinetics was conducted to see the release pattern of the system, which took 250 h for 100% drug release This kind of system may carry the drug for a long time in the circulatory system and prevent the drug discharge. Other cell culture assays such as 3-(4, 5-dimethyl thiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) and reactive oxygen species (ROS) monitoring were used to see the effect of inducers on the cellular system. MTT assay showed cell toxicity of MTX-NLPHS reduced at the lower concentration of the MTX, however, toxicity increased at the higher concentration of the MTX as compared to free MTX. ROS monitoring c revealed more scavenging of ROS using MTX-NLPHS as compared to free MTX. Confocal microscopy suggested the MTX-NLPHS induced more nuclear elongation with cell shrinkage comparatively. Ivyspring International Publisher 2023-01-16 /pmc/articles/PMC9925353/ /pubmed/36793351 http://dx.doi.org/10.7150/ntno.81173 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Kumar, Rahul
Srivastava, Vinish Ranjan
Mahapatra, Supratim
Dkhar, Daphika S
Kumari, Rohini
Prerna, Kumari
Dubey, Vikash Kumar
Chandra, Pranjal
Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer
title Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer
title_full Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer
title_fullStr Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer
title_full_unstemmed Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer
title_short Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer
title_sort drug encapsulated lipid-polymeric nanohybrid as a chemo-therapeutic platform of cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925353/
https://www.ncbi.nlm.nih.gov/pubmed/36793351
http://dx.doi.org/10.7150/ntno.81173
work_keys_str_mv AT kumarrahul drugencapsulatedlipidpolymericnanohybridasachemotherapeuticplatformofcancer
AT srivastavavinishranjan drugencapsulatedlipidpolymericnanohybridasachemotherapeuticplatformofcancer
AT mahapatrasupratim drugencapsulatedlipidpolymericnanohybridasachemotherapeuticplatformofcancer
AT dkhardaphikas drugencapsulatedlipidpolymericnanohybridasachemotherapeuticplatformofcancer
AT kumarirohini drugencapsulatedlipidpolymericnanohybridasachemotherapeuticplatformofcancer
AT prernakumari drugencapsulatedlipidpolymericnanohybridasachemotherapeuticplatformofcancer
AT dubeyvikashkumar drugencapsulatedlipidpolymericnanohybridasachemotherapeuticplatformofcancer
AT chandrapranjal drugencapsulatedlipidpolymericnanohybridasachemotherapeuticplatformofcancer